E-Qure Corp.
E-Qure Corp. (EQUR) Stock Overview
Explore E-Qure Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
6.9K
P/E Ratio
-0.01
EPS (TTM)
$-0.03
ROE
1.75%
EQUR Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of E-Qure Corp. (EQUR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 6.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.
Ohad Goren
1
20 West 64th Street, New York City, NY
1994